Symphony Financial Ltd. Co. Sells 1,868 Shares of Elevance Health, Inc. $ELV

Symphony Financial Ltd. Co. decreased its position in Elevance Health, Inc. (NYSE:ELV) by 71.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 763 shares of the company’s stock after selling 1,868 shares during the period. Symphony Financial Ltd. Co.’s holdings in Elevance Health were worth $245,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nilsine Partners LLC grew its holdings in Elevance Health by 1.5% in the 3rd quarter. Nilsine Partners LLC now owns 1,918 shares of the company’s stock worth $620,000 after acquiring an additional 29 shares during the last quarter. HBK Sorce Advisory LLC grew its stake in shares of Elevance Health by 4.4% in the third quarter. HBK Sorce Advisory LLC now owns 743 shares of the company’s stock worth $260,000 after purchasing an additional 31 shares during the last quarter. Detalus Advisors LLC increased its holdings in Elevance Health by 1.8% during the 3rd quarter. Detalus Advisors LLC now owns 1,726 shares of the company’s stock valued at $558,000 after purchasing an additional 31 shares during the period. Forum Financial Management LP raised its position in Elevance Health by 1.1% during the 3rd quarter. Forum Financial Management LP now owns 2,971 shares of the company’s stock valued at $960,000 after purchasing an additional 33 shares during the last quarter. Finally, Vermillion & White Wealth Management Group LLC lifted its holdings in Elevance Health by 94.9% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock worth $30,000 after buying an additional 37 shares during the period. 89.24% of the stock is currently owned by institutional investors.

Elevance Health Price Performance

Shares of NYSE:ELV opened at $370.77 on Monday. Elevance Health, Inc. has a twelve month low of $273.71 and a twelve month high of $458.75. The stock has a market capitalization of $82.40 billion, a PE ratio of 15.16, a price-to-earnings-growth ratio of 1.91 and a beta of 0.51. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.71. The firm’s 50 day moving average price is $349.17 and its 200-day moving average price is $328.67.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on ELV shares. JPMorgan Chase & Co. boosted their target price on Elevance Health from $384.00 to $394.00 and gave the company an “overweight” rating in a research note on Tuesday, October 28th. Morgan Stanley dropped their target price on shares of Elevance Health from $359.00 to $352.00 and set an “equal weight” rating on the stock in a report on Wednesday, December 17th. Sanford C. Bernstein restated an “outperform” rating and issued a $431.00 price target on shares of Elevance Health in a research note on Tuesday, January 6th. TD Cowen restated a “buy” rating on shares of Elevance Health in a research note on Wednesday, November 26th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $320.00 target price (down previously from $332.00) on shares of Elevance Health in a report on Friday, December 19th. Twelve analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $399.63.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.